Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2009
07/09/2009WO2009085230A1 Inhibitors of pi3 kinase
07/09/2009WO2009084283A1 Cyclic compound, its metal complex, and modified metal complex
07/09/2009WO2009084024A2 A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
07/09/2009WO2009083436A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
07/09/2009WO2009083197A2 Asymmetric phenanthrolines, preparation process therefore and doped organic semiconductor material containing them
07/09/2009WO2009034029A3 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists
07/09/2009WO2008130368A3 Transcription factor modulating compounds and methods of use thereof
07/09/2009US20090176986 Process for the Preparation of Pyridine Heterocycle Cgrp Antagonist Intermediate
07/09/2009US20090176985 Method for converting perylen-3,4:9,10-tetracarboxylic acid diimides into a form suitable for use as a fluorescent dye
07/09/2009US20090176980 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
07/09/2009US20090176825 Prolyl hydroxylase inhibitors
07/09/2009US20090176824 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative technical field
07/09/2009US20090176823 Secondary Amines as Renin Inhibitors
07/09/2009US20090176822 Pyrrolidine inhibitors of iap
07/09/2009US20090176821 Amide and Carbamate Derivatives of Alkyl Substituted N-[4-(4-Amino-1H-Imidazo[4,5-C] Quinolin-1-YL)Butyl]Methanesulfonamides and Methods
07/09/2009US20090176811 Substituted 5,6,7,8-Tetrahydro-pyrido[4,3-d]pyrimidine-2-yl Compounds and 5,6,7,8-Tetrahydro-quinazoline-2-yl Compounds
07/09/2009US20090176807 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
07/09/2009US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
07/09/2009US20090176778 Certain nitrogen containing bicyclic chemical entities for treating viral infections
07/09/2009US20090176777 Imidazo (1,2-a)Pyridin-3-YL-Acetic Acid Hydrazides, Proesses for Their Preparation and Pharmaceutical Uses Thereof
07/09/2009US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use
07/09/2009US20090176774 Compounds and methods of use
07/09/2009US20090176771 Gyrase inhibitors and uses thereof
07/09/2009US20090176769 Cgrp receptor antagonists
07/09/2009US20090176763 Azaindoles useful as inhibitors of JAK and other protein kinases
07/09/2009US20090176760 Tricyclic compounds
07/09/2009US20090176758 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis
07/09/2009US20090176752 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer
07/09/2009US20090176645 Catalysts and methods for catalytic oxidation
07/09/2009CA2710808A1 Cyclic compound, its metal complex and modified metal complex
07/09/2009CA2710452A1 Imidazo [1,2-a] pyridine compounds
07/09/2009CA2710194A1 Inhibitors of p13 kinase
07/09/2009CA2707339A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
07/09/2009CA2704125A1 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents
07/08/2009EP2076514A1 Spiro (furo ý3, 2-c¨pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
07/08/2009EP2076513A1 Compositions and methods for modulating c-kit and pdgfr receptors
07/08/2009EP2076506A2 Heterocyclic-substituted piperidines as orl-1 ligands
07/08/2009EP1869038B1 Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs
07/08/2009EP1592686B1 Gyrase inhibitors and uses thereof
07/08/2009EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
07/08/2009CN101479266A Spiro condensed piperidnes as modulators of muscarinic receptors
07/08/2009CN101479265A Urea derivatives of tropane, their preparation and their therapeutic application
07/08/2009CN101479264A Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B]pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
07/08/2009CN101479263A Pharmaceutical compounds
07/08/2009CN101475571A Beta-carbolines cell cycle protein related kinase 2 inhibitor and use thereof
07/08/2009CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
07/08/2009CN100509827C 电致发光材料 Electroluminescent material
07/08/2009CN100509812C Process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
07/08/2009CN100509811C Azaindoles
07/08/2009CN100509810C Substituted beta-carbolines
07/08/2009CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
07/08/2009CN100509797C Thiophene derivatives used as antiviral agent against flavivirus infections
07/08/2009CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase
07/08/2009CN100508975C Use of pyrazolopyridine compound
07/07/2009US7557212 Tricyclic derivatives as LTD4 antagonists
07/07/2009US7557125 Fab I inhibitors
07/07/2009US7557124 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
07/07/2009US7557122 Pyrrolopyridine compounds, method of making them and uses thereof
07/07/2009US7557121 Tetrahydronaphthyridine derivatives
07/07/2009US7557120 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
07/07/2009US7557118 4-Phenyl-6H-(1)Benzopyrano(4',3':4,5)pyrrolo(2,1-a)isoquinolin-6-one's and analogues, optionally mixed with acceptable carriers, excipients or diluents, used for treating multidrug resistant tumors, for inducing apoptosis and as immunology modulators
07/07/2009US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives
07/07/2009US7557116 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1H-pyrano[2,3d 6,5-d′]dipyrimidyne and 10-aza-analogue thereof
07/07/2009US7557115 Compounds for modulation of kinesins as anticancer agents with administering
07/07/2009US7557114 Heterocyclic-substituted phenyl methanones
07/07/2009CA2523261C Fused pyrimidine derivatives with crf activity
07/07/2009CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
07/07/2009CA2450033C Viral polymerase inhibitors
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/07/2009CA2378834C Pyrazinones, compositions containing such compounds
07/02/2009WO2009082268A2 LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF
07/02/2009WO2009082247A1 Process for preparing immucillins having a methylene link
07/02/2009WO2009082134A2 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent
07/02/2009WO2009081246A2 Bicyclic diamines as nicotinic receptor agonists
07/02/2009WO2009081197A1 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
07/02/2009WO2009080721A2 4 -aminopyrimidine derivatives as histamine h4 receptor antagonists
07/02/2009WO2009080534A1 Heterocyclic antiviral compounds
07/02/2009WO2009080500A1 Process for the preparation of pyrido [2,1-a] isoquinoline derivatives
07/02/2009WO2009080488A1 Spiroindolinone derivatives as anticancer agents
07/02/2009WO2009080291A1 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
07/02/2009WO2009080198A1 Fused cynopryridines and the use thereof
07/02/2009WO2009080197A1 Substituted pyrrolo[2, 3-b] and pyrazolo[3, 4-b] pyridines for use as adenosine receptor ligands
07/02/2009WO2009079767A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
07/02/2009WO2009079765A1 Compounds with activity at the 5-ht2c receptor
07/02/2009WO2009079683A1 Translocator protein ligands
07/02/2009WO2009058944A3 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and /or nf- kappa b activity and use thereof
07/02/2009WO2009037001A4 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
07/02/2009WO2008071918A8 Pyrido-pyrazine derivatives useful as herbicidal compounds
07/02/2009US20090171089 1,6 naphthridines useful as inhibitors of syk kinase
07/02/2009US20090171082 Mitotic kinesin inhibitors
07/02/2009US20090170941 Pharmaceutical Compounds
07/02/2009US20090170922 Benzimidazole derivatives and their use as a medicament
07/02/2009US20090170921 Benzimidazole derivatives
07/02/2009US20090170895 S1p3 receptor antagonist
07/02/2009US20090170893 Novel hydrate form
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170863 Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators
07/02/2009US20090170856 Heterocyclic antiviral compounds
07/02/2009US20090170855 Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
07/02/2009US20090170854 New Use